ARS Pharmaceuticals, Inc.SPRYNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 18 | 6↓69.1% | 1↓76.1% | 0↓97.7% | 89↑297063.3% |
| Gross Profit | 4 | 5↑40.6% | 1↓75.1% | 0↓97.7% | 69↑228540.0% |
| Operating Income | -0 | -19↓4048.0% | -36↓82.6% | -68↓90.1% | -3↑95.4% |
| Net Income | -1 | -20↓1800.8% | -35↓71.3% | -54↓56.8% | 8↑114.7% |
| EBITDA | -0 | -19↓4055.7% | -35↓82.9% | -67↓91.6% | -3↑95.5% |
| EPS Diluted | -0.03 | -0.70↓2180.1% | -0.87↓24.3% | -0.57↑34.5% | 0.08↑113.7% |